Filing Details
- Accession Number:
- 0001209191-15-036794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-28 19:59:16
- Reporting Period:
- 2015-04-24
- Filing Date:
- 2015-04-28
- Accepted Time:
- 2015-04-28 19:59:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1266275 | Kate Mitchell | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1308328 | Bavp, L.p. | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1308343 | Scale Venture Management I, Llc | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1366969 | Rory O'driscoll | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-04-24 | 1,438 | $5.03 | 4,486,591 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-04-27 | 1,676 | $5.00 | 4,484,915 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $5.00 to $5.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares are held by BAVP, LP ("BAVP"). The General Partner of BAVP is Scale Venture Management I, LLC ("Scale"). Kate Mitchell and Rory O'Driscoll are the managing members of Scale and share voting and investment power with respect to these shares. Each of the managing members of Scale disclaims beneficial ownership with respect to these shares except to the extent of their pecuniary interest therein.
- The shares were sold at prices ranging from $5.00 to $5.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.